(-)-alpha-phellandrene increases expression ISO RGD:1347509 6480464 alpha phellandrene results in increased expression of CFLAR mRNA CTD PMID:25075043 (-)-demecolcine increases expression ISO RGD:1347509 6480464 Demecolcine results in increased expression of CFLAR mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1347509 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CFLAR mRNA CTD PMID:22079256 1'-acetoxychavicol acetate multiple interactions ISO RGD:1347509 6480464 1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of CFLAR protein] CTD PMID:15905586 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression EXP 6480464 o, p'-DDT analog results in decreased expression of CFLAR mRNA CTD PMID:22937105 1,1-dichloroethene decreases expression ISO RGD:731977 6480464 vinylidene chloride results in decreased expression of CFLAR mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO RGD:731977 6480464 1, 2-Dimethylhydrazine results in decreased expression of CFLAR mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:731977 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of CFLAR mRNA] CTD PMID:22206623 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of CFLAR mRNA CTD PMID:22841810 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression ISO RGD:731977 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:15329391 15-deoxy-Delta(12,14)-prostaglandin J2 decreases expression ISO RGD:1347509 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 results in decreased expression of CFLAR protein CTD PMID:15498850 17beta-estradiol affects expression ISO RGD:1347509 6480464 Estradiol affects the expression of CFLAR mRNA CTD PMID:21826169 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1347509 6480464 2 more ... CTD PMID:27589474 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:731977 6480464 Tetrachlorodibenzodioxin results in increased expression of CFLAR mRNA CTD PMID:12167310 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1347509 6480464 Tetrachlorodibenzodioxin results in decreased expression of CFLAR mRNA CTD PMID:31536130 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731977 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CFLAR mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CFLAR mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CFLAR mRNA CTD PMID:19520675 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:731977 6480464 Tetrachlorodibenzodioxin results in decreased expression of CFLAR mRNA, Tetrachlorodibenzodioxin results in decreased expression of CFLAR protein CTD PMID:18334599 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of CFLAR mRNA CTD PMID:21346803 2-amino-2-deoxy-D-galactopyranose multiple interactions ISO RGD:731977 6480464 [Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CFLAR protein more ... CTD PMID:20850421 2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid multiple interactions ISO RGD:1347509 6480464 anacardic acid inhibits the reaction [TNF protein results in increased expression of CFLAR protein] CTD PMID:18349320 3,4-methylenedioxymethamphetamine increases expression ISO RGD:731977 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of CFLAR mRNA CTD PMID:20188158 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:731977 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of CFLAR mRNA CTD PMID:26251327 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of CFLAR protein CTD PMID:34915118 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1347509 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CFLAR mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression ISO RGD:731977 6480464 4, 4'-diaminodiphenylmethane results in increased expression of CFLAR mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1347509 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CFLAR mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CFLAR mRNA CTD PMID:36041667 4-(4-chloro-2-methylphenoxy)-N-hydroxybutanamide decreases expression ISO RGD:1347509 6480464 4-(4-chloro-2-methylphenoxy)-N-hydroxybutanamide results in decreased expression of CFLAR mRNA, 4-(4-chloro-2-methylphenoxy)-N-hydroxybutanamide results in decreased expression of CFLAR protein CTD PMID:20446019 4-hydroxyphenyl retinamide multiple interactions ISO RGD:1347509 6480464 Fenretinide inhibits the reaction [TNF protein results in increased expression of CFLAR protein] CTD PMID:16230421 4-hydroxyphenyl retinamide decreases expression ISO RGD:1347509 6480464 Fenretinide results in decreased expression of CFLAR protein CTD PMID:16230421 4-nitrophenol decreases expression ISO RGD:731977 6480464 4-nitrophenol results in decreased expression of CFLAR mRNA CTD PMID:34673133 5-aza-2'-deoxycytidine affects expression ISO RGD:1347509 6480464 Decitabine affects the expression of CFLAR protein CTD PMID:18636160 5-fluorouracil multiple interactions ISO RGD:1347509 6480464 [Fluorouracil co-treated with IFNA1 protein] results in decreased expression of CFLAR protein more ... CTD PMID:16373718 more ... 5-fluorouracil affects response to substance ISO RGD:1347509 6480464 CFLAR protein affects the susceptibility to Fluorouracil CTD PMID:15548681 more ... 5-fluorouracil decreases expression ISO RGD:1347509 6480464 Fluorouracil results in decreased expression of CFLAR mRNA, Fluorouracil results in decreased expression of CFLAR protein CTD PMID:16373718 more ... 5-fluorouracil increases expression ISO RGD:1347509 6480464 Fluorouracil results in increased expression of CFLAR mRNA CTD PMID:15152939 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CFLAR mRNA CTD PMID:24780913 8-Br-cAMP multiple interactions ISO RGD:1347509 6480464 [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CFLAR protein alternative form CTD PMID:16709600 [6]-Shogaol decreases expression ISO RGD:1347509 6480464 shogaol results in decreased expression of CFLAR protein modified form CTD PMID:25619640 [6]-Shogaol multiple interactions ISO RGD:1347509 6480464 Acetylcysteine inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]] more ... CTD PMID:25619640 acetylsalicylic acid increases expression ISO RGD:1347509 6480464 Aspirin results in increased expression of CFLAR mRNA CTD PMID:20457246 acetylsalicylic acid multiple interactions ISO RGD:731977 6480464 Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein] CTD PMID:25449198 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of CFLAR mRNA CTD PMID:28959563 actinomycin D decreases expression ISO RGD:1347509 6480464 Dactinomycin results in decreased expression of CFLAR protein CTD PMID:11234897 , PMID:14601052 adenosine decreases expression ISO RGD:1347509 6480464 Adenosine results in decreased expression of CFLAR mRNA more ... CTD PMID:17303086 adenosine multiple interactions ISO RGD:1347509 6480464 Dipyridamole inhibits the reaction [Adenosine results in decreased expression of CFLAR mRNA alternative form] more ... CTD PMID:17303086 aflatoxin B1 increases expression ISO RGD:731977 6480464 Aflatoxin B1 results in increased expression of CFLAR mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO RGD:1347509 6480464 Aflatoxin B1 results in increased methylation of CFLAR gene CTD PMID:28458013 all-trans-retinoic acid multiple interactions ISO RGD:1347509 6480464 [Tretinoin co-treated with TGFB1 protein] results in increased expression of CFLAR protein, Tretinoin promotes the reaction [rosiglitazone results in decreased expression of CFLAR mRNA] CTD PMID:16242776 more ... all-trans-retinoic acid increases expression ISO RGD:1347509 6480464 Tretinoin results in increased expression of CFLAR mRNA CTD PMID:21934132 , PMID:33167477 alpha-phellandrene increases expression ISO RGD:1347509 6480464 alpha phellandrene results in increased expression of CFLAR mRNA CTD PMID:25075043 alvocidib multiple interactions ISO RGD:1347509 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [alvocidib results in decreased expression of CFLAR protein] CTD PMID:16951203 alvocidib decreases expression ISO RGD:1347509 6480464 alvocidib results in decreased expression of CFLAR, alvocidib results in decreased expression of CFLAR protein CTD PMID:16820931 , PMID:16951203 alvocidib affects expression ISO RGD:1347509 6480464 alvocidib affects the expression of CFLAR mRNA CTD PMID:16951203 amiodarone decreases expression EXP 6480464 Amiodarone results in decreased expression of CFLAR protein CTD PMID:21224497 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CFLAR mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:1347509 6480464 Antirheumatic Agents results in decreased expression of CFLAR mRNA CTD PMID:17696278 antirheumatic drug increases expression ISO RGD:1347509 6480464 Antirheumatic Agents results in increased expression of CFLAR mRNA CTD PMID:24449571 aristolochic acid A multiple interactions EXP 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of CFLAR mRNA CTD PMID:23912714 aristolochic acid A increases expression ISO RGD:1347509 6480464 aristolochic acid I results in increased expression of CFLAR mRNA CTD PMID:33212167 arsenous acid decreases expression ISO RGD:1347509 6480464 Arsenic Trioxide results in decreased expression of CFLAR mRNA more ... CTD PMID:16105982 more ... arsenous acid multiple interactions ISO RGD:1347509 6480464 [Arsenic Trioxide co-treated with TNF protein] results in decreased expression of CFLAR protein more ... CTD PMID:17673311 , PMID:23082001 arsenous acid increases expression ISO RGD:1347509 6480464 Arsenic Trioxide results in increased expression of CFLAR mRNA CTD PMID:22521957 arsenous acid decreases response to substance ISO RGD:1347509 6480464 CFLAR protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:16105982 baicalein multiple interactions ISO RGD:731977 6480464 baicalein inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CFLAR protein] CTD PMID:20850421 beauvericin increases expression ISO RGD:1347509 6480464 beauvericin results in increased expression of CFLAR mRNA CTD PMID:29203277 benzo[a]pyrene multiple interactions ISO RGD:731977 6480464 AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of CFLAR mRNA] CTD PMID:15034205 benzo[a]pyrene affects methylation ISO RGD:1347509 6480464 Benzo(a)pyrene affects the methylation of CFLAR 5' UTR CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1347509 6480464 Benzo(a)pyrene results in increased methylation of CFLAR promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:731977 6480464 Benzo(a)pyrene results in decreased expression of CFLAR mRNA CTD PMID:15034205 beta-carotene increases expression ISO RGD:1347509 6480464 beta Carotene results in increased expression of CFLAR mRNA CTD PMID:17034753 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:731977 6480464 Diethylhexyl Phthalate results in decreased expression of CFLAR mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:731977 6480464 PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of CFLAR mRNA] CTD PMID:19850644 bisphenol A affects expression ISO RGD:1347509 6480464 bisphenol A affects the expression of CFLAR mRNA CTD PMID:21826169 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CFLAR mRNA CTD PMID:36041667 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CFLAR mRNA CTD PMID:34947998 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CFLAR mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:731977 6480464 bisphenol A results in increased expression of CFLAR mRNA CTD PMID:22687993 bisphenol A decreases expression ISO RGD:1347509 6480464 bisphenol A results in decreased expression of CFLAR mRNA CTD PMID:20678512 , PMID:29275510 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CFLAR mRNA CTD PMID:36041667 bortezomib multiple interactions ISO RGD:1347509 6480464 [Bortezomib co-treated with TNFSF10 protein] results in decreased expression of CFLAR protein more ... CTD PMID:17659339 more ... bortezomib decreases response to substance ISO RGD:1347509 6480464 CFLAR protein alternative form results in decreased susceptibility to Bortezomib, CFLAR results in decreased susceptibility to Bortezomib CTD PMID:17510429 bortezomib decreases expression ISO RGD:1347509 6480464 Bortezomib results in decreased expression of CFLAR mRNA, Bortezomib results in decreased expression of CFLAR protein CTD PMID:17327374 more ... bortezomib increases expression ISO RGD:1347509 6480464 Bortezomib results in increased expression of CFLAR protein more ... CTD PMID:17351739 more ... bortezomib affects expression ISO RGD:1347509 6480464 Bortezomib affects the expression of CFLAR protein CTD PMID:17326159 butanal decreases expression ISO RGD:1347509 6480464 butyraldehyde results in decreased expression of CFLAR mRNA CTD PMID:26079696 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of CFLAR mRNA CTD PMID:19010381 cafestol decreases expression ISO RGD:1347509 6480464 cafestol results in decreased expression of CFLAR protein CTD PMID:21334318 camptothecin multiple interactions ISO RGD:731977 6480464 Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein] CTD PMID:25449198 cannabidiol increases expression ISO RGD:731977 6480464 Cannabidiol results in increased expression of CFLAR mRNA CTD PMID:30742662 cannabidiol multiple interactions ISO RGD:1347509 6480464 [Cannabidiol co-treated with moringin] results in decreased expression of CFLAR mRNA, [PSEN1 protein affects the susceptibility to Cannabidiol] which affects the expression of CFLAR mRNA CTD PMID:30096889 , PMID:33096116 capsaicin decreases expression ISO RGD:1347509 6480464 Capsaicin results in decreased expression of CFLAR protein alternative form CTD PMID:19939880 capsaicin increases expression ISO RGD:1347509 6480464 Capsaicin results in increased expression of CFLAR mRNA CTD PMID:19502594 carbamazepine affects expression ISO RGD:1347509 6480464 Carbamazepine affects the expression of CFLAR mRNA CTD PMID:24752500 carbon nanotube increases expression ISO RGD:731977 6480464 Nanotubes, Carbon results in increased expression of CFLAR mRNA CTD PMID:25554681 , PMID:25620056 Cardanol decreases expression ISO RGD:1347509 6480464 cardanol results in decreased expression of CFLAR mRNA CTD PMID:26694491 celecoxib decreases expression ISO RGD:1347509 6480464 Celecoxib results in decreased expression of CFLAR CTD PMID:17145853 choline multiple interactions ISO RGD:731977 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CFLAR gene CTD PMID:20938992 ciguatoxin CTX1B affects expression ISO RGD:731977 6480464 Ciguatoxins affects the expression of CFLAR mRNA CTD PMID:18353800 cisplatin decreases expression ISO RGD:1347509 6480464 Cisplatin results in decreased expression of CFLAR protein CTD PMID:14601052 , PMID:20876774 cisplatin multiple interactions ISO RGD:1347509 6480464 [Cisplatin results in decreased expression of CFLAR protein] which results in increased susceptibility to TNFSF10 protein, [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of CFLAR mRNA CTD PMID:20876774 , PMID:30871063 cisplatin decreases response to substance ISO RGD:731977 6480464 CFLAR protein results in decreased susceptibility to Cisplatin CTD PMID:20683665 clofibrate decreases expression ISO RGD:731977 6480464 Clofibrate results in decreased expression of CFLAR mRNA CTD PMID:23811191 cobalt dichloride multiple interactions ISO RGD:1347509 6480464 lysophosphatidylethanolamine analog inhibits the reaction [cobaltous chloride results in decreased expression of CFLAR mRNA] CTD PMID:25125499 cobalt dichloride decreases expression ISO RGD:1347509 6480464 cobaltous chloride results in decreased expression of CFLAR mRNA CTD PMID:25125499 cocaine affects expression ISO RGD:731977 6480464 Cocaine affects the expression of CFLAR mRNA CTD PMID:15681117 copper atom multiple interactions ISO RGD:1347509 6480464 [Chelating Agents binds to Copper] which results in increased expression of CFLAR mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:1347509 6480464 [Chelating Agents binds to Copper] which results in increased expression of CFLAR mRNA CTD PMID:30911355 coumestrol decreases expression ISO RGD:1347509 6480464 Coumestrol results in decreased expression of CFLAR mRNA CTD PMID:19167446 crocidolite asbestos decreases expression ISO RGD:731977 6480464 Asbestos, Crocidolite results in decreased expression of CFLAR mRNA CTD PMID:29279043 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of CFLAR mRNA CTD PMID:26577399 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of CFLAR mRNA CTD PMID:27523638 curcumin multiple interactions ISO RGD:1347509 6480464 Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of CFLAR mRNA], Curcumin inhibits the reaction [TNF protein results in increased expression of CFLAR mRNA] CTD PMID:16219905 , PMID:23452621 curcumin decreases expression ISO RGD:1347509 6480464 Curcumin results in decreased expression of CFLAR protein CTD PMID:16173963 cycloheximide decreases expression ISO RGD:1347509 6480464 Cycloheximide results in decreased expression of CFLAR protein more ... CTD PMID:12663669 more ... cycloheximide multiple interactions ISO RGD:1347509 6480464 shogaol promotes the reaction [Cycloheximide results in decreased expression of CFLAR protein modified form] CTD PMID:25619640 deguelin multiple interactions ISO RGD:1347509 6480464 deguelin inhibits the reaction [TNF protein results in increased expression of CFLAR mRNA] CTD PMID:22623043 deguelin decreases expression ISO RGD:1347509 6480464 deguelin results in decreased expression of CFLAR mRNA CTD PMID:22623043 dexamethasone increases expression ISO RGD:1347509 6480464 Dexamethasone results in increased expression of CFLAR, Dexamethasone results in increased expression of CFLAR mRNA CTD PMID:21244764 , PMID:25047013 dexamethasone multiple interactions ISO RGD:1347509 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CFLAR mRNA, Mifepristone inhibits the reaction [Dexamethasone results in increased expression of CFLAR] CTD PMID:21244764 , PMID:28628672 dextran sulfate multiple interactions ISO RGD:731977 6480464 [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein more ... CTD PMID:25449198 diallyl trisulfide decreases expression ISO RGD:1347509 6480464 diallyl trisulfide results in decreased expression of CFLAR protein CTD PMID:25205294 diarsenic trioxide decreases expression ISO RGD:1347509 6480464 Arsenic Trioxide results in decreased expression of CFLAR mRNA more ... CTD PMID:16105982 more ... diarsenic trioxide multiple interactions ISO RGD:1347509 6480464 [Arsenic Trioxide co-treated with TNF protein] results in decreased expression of CFLAR protein more ... CTD PMID:17673311 , PMID:23082001 diarsenic trioxide decreases response to substance ISO RGD:1347509 6480464 CFLAR protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:16105982 diarsenic trioxide increases expression ISO RGD:1347509 6480464 Arsenic Trioxide results in increased expression of CFLAR mRNA CTD PMID:22521957 diazinon multiple interactions ISO RGD:1347509 6480464 [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of CFLAR mRNA] more ... CTD PMID:27920530 diazinon increases expression ISO RGD:1347509 6480464 Diazinon results in increased expression of CFLAR mRNA CTD PMID:27920530 dibenz[a,h]anthracene decreases expression ISO RGD:731977 6480464 1 more ... CTD PMID:26377693 diclofenac multiple interactions ISO RGD:1347509 6480464 [Diclofenac co-treated with Hyaluronic Acid] results in decreased expression of CFLAR protein CTD PMID:20237495 diclofenac affects expression ISO RGD:1347509 6480464 Diclofenac affects the expression of CFLAR mRNA CTD PMID:24752500 diethyl maleate decreases expression EXP 6480464 diethyl maleate results in decreased expression of CFLAR mRNA CTD PMID:21161181 dimethyl sulfoxide affects expression ISO RGD:1347509 6480464 Dimethyl Sulfoxide affects the expression of CFLAR mRNA CTD PMID:24834073 diosgenin decreases expression ISO RGD:1347509 6480464 Diosgenin results in decreased expression of CFLAR protein CTD PMID:16331273 diosgenin multiple interactions ISO RGD:1347509 6480464 Diosgenin inhibits the reaction [TNF protein results in increased expression of CFLAR protein] CTD PMID:16331273 dioxygen multiple interactions ISO RGD:1347509 6480464 3 more ... CTD PMID:23452621 dioxygen increases expression ISO RGD:1347509 6480464 Oxygen deficiency results in increased expression of CFLAR mRNA CTD PMID:23452621 dipyridamole multiple interactions ISO RGD:1347509 6480464 Dipyridamole inhibits the reaction [Adenosine results in decreased expression of CFLAR mRNA alternative form] more ... CTD PMID:17303086 diuron increases expression EXP 6480464 Diuron results in increased expression of CFLAR mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:1347509 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1347509 6480464 Doxorubicin results in decreased expression of CFLAR protein CTD PMID:14601052 , PMID:15897917 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of CFLAR protein CTD PMID:15703961 elemental selenium multiple interactions ISO RGD:1347509 6480464 [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of CFLAR mRNA], Selenium analog promotes the reaction [Diazinon results in increased expression of CFLAR mRNA] CTD PMID:27920530 entinostat decreases expression ISO RGD:1347509 6480464 entinostat results in decreased expression of CFLAR mRNA CTD PMID:26272509 , PMID:27188386 entinostat multiple interactions ISO RGD:1347509 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFLAR mRNA CTD PMID:27188386 epoxiconazole decreases expression ISO RGD:731977 6480464 epoxiconazole results in decreased expression of CFLAR mRNA CTD PMID:35436446 epoxomicin affects expression ISO RGD:1347509 6480464 epoxomicin affects the expression of CFLAR protein alternative form CTD PMID:17510429 etacrynic acid multiple interactions ISO RGD:1347509 6480464 arsenic trioxide promotes the reaction [Ethacrynic Acid results in decreased expression of CFLAR protein] CTD PMID:23082001 etacrynic acid decreases expression ISO RGD:1347509 6480464 Ethacrynic Acid results in decreased expression of CFLAR protein CTD PMID:23082001 ethanol increases expression ISO RGD:731977 6480464 Ethanol results in increased expression of CFLAR mRNA, Ethanol results in increased expression of CFLAR protein CTD PMID:19429258 , PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:1347509 6480464 Ethyl Methanesulfonate results in increased expression of CFLAR mRNA CTD PMID:23649840 etoposide increases expression ISO RGD:1347509 6480464 Etoposide results in increased expression of CFLAR protein CTD PMID:14601052 Evodiamine multiple interactions ISO RGD:1347509 6480464 evodiamine inhibits the reaction [TNF protein results in increased expression of CFLAR protein] CTD PMID:15710601 folic acid multiple interactions ISO RGD:731977 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CFLAR gene more ... CTD PMID:20938992 , PMID:22206623 formaldehyde increases expression ISO RGD:1347509 6480464 Formaldehyde results in increased expression of CFLAR mRNA CTD PMID:23649840 formaldehyde decreases expression ISO RGD:1347509 6480464 Formaldehyde results in decreased expression of CFLAR mRNA CTD PMID:27905399 genistein multiple interactions ISO RGD:1347509 6480464 Genistein inhibits the reaction [Oxygen deficiency results in increased expression of CFLAR mRNA] CTD PMID:23452621 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CFLAR mRNA CTD PMID:33387578 gingerol multiple interactions ISO RGD:1347509 6480464 Acetylcysteine inhibits the reaction [gingerol results in decreased expression of CFLAR protein] CTD PMID:25034532 gingerol decreases expression ISO RGD:1347509 6480464 gingerol results in decreased expression of CFLAR protein CTD PMID:25034532 Glutathione ethyl ester multiple interactions ISO RGD:1347509 6480464 S-ethyl glutathione inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]] CTD PMID:25619640 glycochenodeoxycholic acid multiple interactions ISO RGD:731977 6480464 Glycochenodeoxycholic Acid promotes the reaction [lysophosphatidylethanolamine analog results in increased expression of CFLAR protein], lysophosphatidylethanolamine analog promotes the reaction [Glycochenodeoxycholic Acid results in increased expression of CFLAR protein] CTD PMID:25125499 glycochenodeoxycholic acid increases expression ISO RGD:731977 6480464 Glycochenodeoxycholic Acid results in increased expression of CFLAR protein CTD PMID:25125499 glycochenodeoxycholic acid multiple interactions ISO RGD:1347509 6480464 Glycochenodeoxycholic Acid results in decreased expression of and results in increased phosphorylation of CFLAR protein CTD PMID:25125499 glyphosate increases expression ISO RGD:1347509 6480464 glyphosate results in increased expression of CFLAR mRNA CTD PMID:31874349 guggulsterone multiple interactions ISO RGD:1347509 6480464 pregna-4 more ... CTD PMID:15322087 hyaluronic acid multiple interactions ISO RGD:1347509 6480464 [Diclofenac co-treated with Hyaluronic Acid] results in decreased expression of CFLAR protein CTD PMID:20237495 hydrogen peroxide increases expression ISO RGD:1347509 6480464 Hydrogen Peroxide results in increased expression of CFLAR protein CTD PMID:18603805 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of CFLAR protein CTD PMID:16157298 hydroquinone increases expression ISO RGD:1347509 6480464 hydroquinone results in increased expression of CFLAR mRNA CTD PMID:31256213 hydroxychloroquine decreases expression ISO RGD:1347509 6480464 Hydroxychloroquine results in decreased expression of CFLAR mRNA, Hydroxychloroquine results in decreased expression of CFLAR protein CTD PMID:16734620 hyperforin decreases expression ISO RGD:1347509 6480464 hyperforin results in decreased expression of CFLAR protein CTD PMID:32485087 ibrutinib decreases expression ISO RGD:1347509 6480464 ibrutinib results in decreased expression of CFLAR mRNA CTD PMID:26254443 idelalisib multiple interactions ISO RGD:1347509 6480464 2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [[FASLG protein co-treated with idelalisib] results in decreased expression of CFLAR protein] more ... CTD PMID:31445927 indole-3-methanol multiple interactions ISO RGD:1347509 6480464 indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of CFLAR protein] CTD PMID:15811958 indole-3-methanol decreases expression ISO RGD:1347509 6480464 indole-3-carbinol results in decreased expression of CFLAR CTD PMID:16082211 indometacin multiple interactions ISO RGD:1347509 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CFLAR mRNA, Indomethacin inhibits the reaction [LTA protein results in increased expression of CFLAR protein] CTD PMID:17873517 , PMID:28628672 indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of CFLAR mRNA CTD PMID:25972201 irinotecan decreases expression ISO RGD:1347509 6480464 Irinotecan results in decreased expression of CFLAR protein CTD PMID:16373718 irinotecan affects response to substance ISO RGD:1347509 6480464 CFLAR protein affects the susceptibility to Irinotecan CTD PMID:16373718 irinotecan multiple interactions ISO RGD:1347509 6480464 CFLAR protein alternative form inhibits the reaction [Irinotecan results in increased activity of TNFSF10 protein] CTD PMID:16373718 jaceosidin decreases expression ISO RGD:1347509 6480464 jaceosidin results in decreased expression of CFLAR mRNA, jaceosidin results in decreased expression of CFLAR protein CTD PMID:27729209 jaceosidin multiple interactions ISO RGD:1347509 6480464 CFLAR protein inhibits the reaction [jaceosidin results in increased cleavage of PARP1 protein] more ... CTD PMID:27729209 L-methionine multiple interactions ISO RGD:731977 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CFLAR gene CTD PMID:20938992 lipopolysaccharide multiple interactions ISO RGD:731977 6480464 [Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CFLAR protein more ... CTD PMID:20850421 lipopolysaccharide multiple interactions ISO RGD:1347509 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CFLAR mRNA CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:1347509 6480464 Lipopolysaccharides results in increased expression of CFLAR mRNA CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:731977 6480464 Lipopolysaccharides results in increased expression of CFLAR mRNA CTD PMID:10975854 lonafarnib multiple interactions ISO RGD:1347509 6480464 lonafarnib inhibits the reaction [TNF protein results in increased expression of CFLAR protein] CTD PMID:15090542 LY294002 decreases expression ISO RGD:1347509 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of CFLAR protein, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of CFLAR protein alternative form CTD PMID:12970779 more ... lysophosphatidylethanolamine multiple interactions ISO RGD:1347509 6480464 lysophosphatidylethanolamine analog inhibits the reaction [cobaltous chloride results in decreased expression of CFLAR mRNA] CTD PMID:25125499 lysophosphatidylethanolamine increases expression ISO RGD:1347509 6480464 lysophosphatidylethanolamine analog results in increased expression of CFLAR mRNA, lysophosphatidylethanolamine analog results in increased expression of CFLAR protein CTD PMID:25125499 lysophosphatidylethanolamine increases expression ISO RGD:731977 6480464 lysophosphatidylethanolamine analog results in increased expression of CFLAR protein CTD PMID:25125499 lysophosphatidylethanolamine multiple interactions ISO RGD:731977 6480464 Glycochenodeoxycholic Acid promotes the reaction [lysophosphatidylethanolamine analog results in increased expression of CFLAR protein], lysophosphatidylethanolamine analog promotes the reaction [Glycochenodeoxycholic Acid results in increased expression of CFLAR protein] CTD PMID:25125499 magnesium oxide multiple interactions ISO RGD:1347509 6480464 [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of CFLAR mRNA], Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of CFLAR mRNA] CTD PMID:27920530 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of CFLAR mRNA CTD PMID:28801915 medroxyprogesterone acetate multiple interactions ISO RGD:1347509 6480464 [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CFLAR protein alternative form CTD PMID:16709600 methotrexate increases expression ISO RGD:1347509 6480464 Methotrexate results in increased expression of CFLAR mRNA CTD PMID:17696278 , PMID:21678067 methylparaben decreases expression ISO RGD:1347509 6480464 methylparaben results in decreased expression of CFLAR mRNA CTD PMID:31745603 methylseleninic acid multiple interactions ISO RGD:1347509 6480464 [2 more ... CTD PMID:18444175 mifepristone multiple interactions ISO RGD:1347509 6480464 Mifepristone inhibits the reaction [Dexamethasone results in increased expression of CFLAR], Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased expression of CFLAR protein modified form]] CTD PMID:12645856 , PMID:21244764 mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of CFLAR mRNA CTD PMID:25972201 Mitotane increases expression EXP 6480464 Mitotane analog results in increased expression of CFLAR mRNA CTD PMID:23485034 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:731977 6480464 [FASL affects the susceptibility to mono-(2-ethylhexyl)phthalate] which affects the expression of CFLAR protein CTD PMID:20100735 N-acetyl-L-cysteine multiple interactions ISO RGD:1347509 6480464 Acetylcysteine inhibits the reaction [CSC-3436 results in decreased expression of CFLAR protein] more ... CTD PMID:25034532 more ... N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal affects expression ISO RGD:1347509 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde affects the expression of CFLAR protein alternative form CTD PMID:17510429 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1347509 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [(+)-JQ1 compound results in decreased expression of CFLAR protein] more ... CTD PMID:16951203 more ... nickel atom increases expression ISO RGD:1347509 6480464 Nickel results in increased expression of CFLAR mRNA CTD PMID:24768652 , PMID:25583101 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of CFLAR mRNA CTD PMID:22546817 nickel sulfate increases expression ISO RGD:1347509 6480464 nickel sulfate results in increased expression of CFLAR mRNA CTD PMID:16780908 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of CFLAR mRNA CTD PMID:18417182 oxaliplatin affects response to substance ISO RGD:1347509 6480464 CFLAR protein affects the susceptibility to oxaliplatin CTD PMID:16373718 oxaliplatin decreases expression ISO RGD:1347509 6480464 oxaliplatin results in decreased expression of CFLAR protein CTD PMID:16373718 oxaliplatin multiple interactions ISO RGD:1347509 6480464 CFLAR protein alternative form inhibits the reaction [oxaliplatin results in increased activity of TNFSF10 protein] CTD PMID:16373718 p-menthan-3-ol increases expression ISO RGD:1347509 6480464 Menthol results in increased expression of CFLAR mRNA CTD PMID:26760959 paclitaxel decreases response to substance ISO RGD:1347509 6480464 CFLAR protein results in decreased susceptibility to Paclitaxel CTD PMID:16080463 panobinostat multiple interactions ISO RGD:1347509 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFLAR mRNA CTD PMID:27188386 paracetamol affects expression ISO RGD:731977 6480464 Acetaminophen affects the expression of CFLAR mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1347509 6480464 Acetaminophen results in decreased expression of CFLAR mRNA CTD PMID:21420995 , PMID:27761495 pemetrexed decreases response to substance ISO RGD:1347509 6480464 CFLAR results in decreased susceptibility to Pemetrexed CTD PMID:21726997 pentanal decreases expression ISO RGD:1347509 6480464 pentanal results in decreased expression of CFLAR mRNA CTD PMID:26079696 Pentoxifylline multiple interactions ISO RGD:1347509 6480464 [Pentoxifylline co-treated with TNFSF10 protein] results in decreased expression of CFLAR protein CTD PMID:20804743 Pentoxifylline decreases expression ISO RGD:1347509 6480464 Pentoxifylline results in decreased expression of CFLAR protein CTD PMID:18851957 perfluorooctanoic acid decreases expression ISO RGD:1347509 6480464 perfluorooctanoic acid results in decreased expression of CFLAR mRNA CTD PMID:25868421 pevonedistat affects expression ISO RGD:1347509 6480464 pevonedistat affects the expression of CFLAR mRNA CTD PMID:24634471 phenobarbital affects expression ISO RGD:1347509 6480464 Phenobarbital affects the expression of CFLAR mRNA CTD PMID:19159669 phenobarbital affects expression ISO RGD:731977 6480464 Phenobarbital affects the expression of CFLAR mRNA CTD PMID:23091169 pirinixic acid decreases expression ISO RGD:731977 6480464 pirinixic acid results in decreased expression of CFLAR mRNA CTD PMID:18445702 , PMID:23811191 potassium chromate decreases expression ISO RGD:1347509 6480464 potassium chromate(VI) results in decreased expression of CFLAR mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1347509 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CFLAR mRNA CTD PMID:22079256 progesterone increases expression EXP 6480464 Progesterone results in increased expression of CFLAR mRNA CTD PMID:21770760 protein kinase inhibitor decreases expression ISO RGD:1347509 6480464 Protein Kinase Inhibitors results in decreased expression of CFLAR protein CTD PMID:21173233 quercetin decreases expression ISO RGD:1347509 6480464 Quercetin results in decreased expression of CFLAR mRNA, Quercetin results in decreased expression of CFLAR protein alternative form CTD PMID:18980244 , PMID:23727915 quercetin multiple interactions ISO RGD:1347509 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Quercetin results in decreased expression of CFLAR protein alternative form] CTD PMID:18980244 rebaudioside A decreases expression ISO RGD:1347509 6480464 rebaudioside A results in decreased expression of CFLAR mRNA CTD PMID:31655124 resveratrol decreases expression ISO RGD:731977 6480464 resveratrol results in decreased expression of CFLAR protein CTD PMID:17872969 resveratrol multiple interactions ISO RGD:731977 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CFLAR mRNA] CTD PMID:31298478 resveratrol decreases cleavage ISO RGD:1347509 6480464 resveratrol results in decreased cleavage of CFLAR protein CTD PMID:18222423 resveratrol multiple interactions ISO RGD:1347509 6480464 [2 more ... CTD PMID:18444175 more ... resveratrol decreases expression ISO RGD:1347509 6480464 resveratrol results in decreased expression of CFLAR protein CTD PMID:20097879 resveratrol increases expression ISO RGD:731977 6480464 resveratrol results in increased expression of CFLAR mRNA CTD PMID:16081268 rifampicin multiple interactions ISO RGD:1347509 6480464 Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased expression of CFLAR protein modified form]], Rifampin inhibits the reaction [FAS protein results in increased expression of CFLAR protein modified form] CTD PMID:12645856 rifampicin increases expression ISO RGD:1347509 6480464 Rifampin results in increased expression of CFLAR protein CTD PMID:11958592 romidepsin multiple interactions ISO RGD:1347509 6480464 [romidepsin co-treated with Bortezomib] results in decreased expression of CFLAR protein CTD PMID:18223231 rubimaillin increases cleavage ISO RGD:1347509 6480464 rubimaillin results in increased cleavage of CFLAR protein CTD PMID:19716835 rubimaillin multiple interactions ISO RGD:1347509 6480464 BCL2L1 protein inhibits the reaction [rubimaillin results in increased cleavage of CFLAR protein] CTD PMID:19716835 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1347509 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CFLAR mRNA CTD PMID:35811015 sarin increases expression ISO RGD:1347509 6480464 Sarin results in increased expression of CFLAR mRNA CTD PMID:19522546 SB 431542 multiple interactions ISO RGD:1347509 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom multiple interactions ISO RGD:1347509 6480464 [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of CFLAR mRNA], Selenium analog promotes the reaction [Diazinon results in increased expression of CFLAR mRNA] CTD PMID:27920530 silicon dioxide increases expression ISO RGD:731977 6480464 Silicon Dioxide results in increased expression of CFLAR mRNA CTD PMID:19073995 silicon dioxide increases expression ISO RGD:1347509 6480464 Silicon Dioxide results in increased expression of CFLAR mRNA CTD PMID:34766707 silver atom decreases expression ISO RGD:731977 6480464 Silver results in decreased expression of CFLAR mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:731977 6480464 Silver results in decreased expression of CFLAR mRNA CTD PMID:27131904 simvastatin multiple interactions ISO RGD:1347509 6480464 Simvastatin inhibits the reaction [TNF protein results in increased expression of CFLAR protein] CTD PMID:17277159 simvastatin increases expression ISO RGD:731977 6480464 Simvastatin results in increased expression of CFLAR mRNA, Simvastatin results in increased expression of CFLAR protein CTD PMID:19262002 simvastatin decreases expression ISO RGD:1347509 6480464 Simvastatin results in decreased expression of CFLAR protein, Simvastatin results in decreased expression of CFLAR protein alternative form CTD PMID:18521906 , PMID:21910007 sodium arsenate decreases expression ISO RGD:731977 6480464 sodium arsenate results in decreased expression of CFLAR mRNA CTD PMID:21795629 sodium arsenite decreases expression ISO RGD:731977 6480464 sodium arsenite results in decreased expression of CFLAR mRNA CTD PMID:19822182 sodium arsenite increases expression ISO RGD:1347509 6480464 sodium arsenite results in increased expression of CFLAR mRNA CTD PMID:12016162 , PMID:20886546 sorafenib decreases expression ISO RGD:1347509 6480464 sorafenib results in decreased expression of CFLAR protein CTD PMID:17909059 sorafenib increases degradation ISO RGD:1347509 6480464 sorafenib results in increased degradation of CFLAR protein CTD PMID:20071162 sorafenib multiple interactions ISO RGD:1347509 6480464 [sorafenib co-treated with TNFSF10 protein] results in decreased expression of CFLAR protein more ... CTD PMID:17909059 , PMID:20071162 steviol decreases expression ISO RGD:1347509 6480464 steviol results in decreased expression of CFLAR mRNA CTD PMID:31655124 stevioside decreases expression ISO RGD:1347509 6480464 stevioside results in decreased expression of CFLAR mRNA CTD PMID:31655124 succimer multiple interactions ISO RGD:731977 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CFLAR mRNA CTD PMID:21641980 succimer multiple interactions ISO RGD:1347509 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CFLAR mRNA CTD PMID:26378955 sulindac sulfide decreases expression ISO RGD:1347509 6480464 sulindac sulfide results in decreased expression of CFLAR protein CTD PMID:11912124 tamoxifen multiple interactions ISO RGD:1347509 6480464 [Tamoxifen co-treated with TNFSF10 protein] results in decreased expression of CFLAR protein modified form CTD PMID:17767197 Tanshinone I increases expression ISO RGD:1347509 6480464 tanshinone results in increased expression of CFLAR protein CTD PMID:26203587 testosterone decreases expression ISO RGD:731977 6480464 Testosterone deficiency results in decreased expression of CFLAR mRNA CTD PMID:33848595 tetrachloromethane increases expression ISO RGD:731977 6480464 Carbon Tetrachloride results in increased expression of CFLAR mRNA CTD PMID:17484886 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of CFLAR mRNA CTD PMID:31150632 thalidomide decreases expression ISO RGD:1347509 6480464 Thalidomide results in decreased expression of CFLAR protein CTD PMID:15986355 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of CFLAR mRNA CTD PMID:23411599 titanium dioxide multiple interactions ISO RGD:731977 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CFLAR mRNA] CTD PMID:31298478 titanium dioxide increases expression ISO RGD:731977 6480464 titanium dioxide results in increased expression of CFLAR mRNA CTD PMID:31298478 trichloroethene decreases expression ISO RGD:731977 6480464 Trichloroethylene results in decreased expression of CFLAR mRNA CTD PMID:19448997 trichostatin A decreases expression ISO RGD:1347509 6480464 trichostatin A results in decreased expression of CFLAR mRNA CTD PMID:28542535 trimethyltin increases expression ISO RGD:731977 6480464 trimethyltin results in increased expression of CFLAR mRNA CTD PMID:21435392 triptonide affects expression ISO RGD:731977 6480464 triptonide affects the expression of CFLAR mRNA CTD PMID:33045310 troglitazone increases expression ISO RGD:731977 6480464 troglitazone results in increased expression of CFLAR mRNA CTD PMID:28973697 troglitazone decreases expression ISO RGD:1347509 6480464 troglitazone results in decreased expression of CFLAR protein CTD PMID:16820965 tunicamycin increases expression ISO RGD:731977 6480464 Tunicamycin results in increased expression of CFLAR mRNA CTD PMID:17127020 Tylophorine increases expression ISO RGD:1347509 6480464 tylophorine analog results in increased expression of CFLAR mRNA CTD PMID:19284764 ursodeoxycholic acid increases expression ISO RGD:1347509 6480464 Ursodeoxycholic Acid analog results in increased expression of CFLAR protein CTD PMID:21146893 valproic acid decreases expression ISO RGD:731977 6480464 Valproic Acid results in decreased expression of CFLAR mRNA CTD PMID:21427059 valproic acid decreases expression ISO RGD:1347509 6480464 Valproic Acid results in decreased expression of CFLAR mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1347509 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFLAR mRNA CTD PMID:27188386 valproic acid affects expression ISO RGD:1347509 6480464 Valproic Acid affects the expression of CFLAR mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of CFLAR mRNA CTD PMID:19015723 vincristine increases expression ISO RGD:1347509 6480464 Vincristine results in increased expression of CFLAR mRNA CTD PMID:23649840 vitamin E increases expression ISO RGD:1347509 6480464 Vitamin E results in increased expression of CFLAR mRNA CTD PMID:19244175 vorinostat multiple interactions ISO RGD:1347509 6480464 [vorinostat co-treated with TNFSF10 protein] affects the localization of CFLAR protein more ... CTD PMID:16377638 , PMID:19643600 vorinostat increases expression ISO RGD:1347509 6480464 vorinostat results in increased expression of CFLAR protein modified form CTD PMID:17351739 vorinostat decreases expression ISO RGD:1347509 6480464 vorinostat results in decreased expression of CFLAR protein, vorinostat results in decreased expression of CFLAR protein modified form CTD PMID:15897598 more ... zerumbone decreases expression ISO RGD:1347509 6480464 zerumbone results in decreased expression of CFLAR mRNA CTD PMID:16007145 zoledronic acid increases expression ISO RGD:1347509 6480464 zoledronic acid results in increased expression of CFLAR mRNA CTD PMID:24714768